Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosberg-Cody, E.
Right arrow Articles by Stanton, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosberg-Cody, E.
Right arrow Articles by Stanton, C.
Agricola
Right arrow Articles by Rosberg-Cody, E.
Right arrow Articles by Stanton, C.
Microbiology 153 (2007), 2483-2490; DOI  10.1099/mic.0.2006/001966-0
© 2007 Society for General Microbiology

Heterologous expression of linoleic acid isomerase from Propionibacterium acnes and anti-proliferative activity of recombinant trans-10, cis-12 conjugated linoleic acid

Eva Rosberg-Cody1,2, Mark C. Johnson1,3, Gerald F. Fitzgerald2,3, Paul R. Ross1,3 and Catherine Stanton1,3

1 Teagasc, Moorepark Food Research, Biotechnology Centre, Fermoy, Co. Cork, Ireland
2 Microbiology Department, University College Cork, Ireland
3 Alimentary Pharmabiotic Centre, Cork, Ireland

Correspondence
Catherine Stanton
catherine.stanton{at}teagasc.ie

The linoleic acid isomerase enzyme from Propionibacterium acnes responsible for bioconversion of linoleic acid to trans-10, cis-12 conjugated linoleic acid (t10, c12 CLA) was cloned and overexpressed in Lactococcus lactis and Escherichia coli, resulting in between 30 and 50 % conversion rates of the substrate linoleic acid to t10, c12 CLA. The anti-proliferative activities of the fatty acids produced following isomerization of linoleic acid by L. lactis and E. coli were assessed using the human SW480 colon cancer cell line. Fatty acids generated from both L. lactis and E. coli contained a mixture of linoleic acid and t10, c12 CLA at a ratio of ~1.35 : 1. Following 5 days of incubation of SW480 cells with 5–20 µg ml–1 (17.8–71.3 µM) of the t10, c12 CLA, there was a significant (P<0.001) reduction in growth of the SW480 cancer cells compared with the linoleic acid control. Cell viability after treatment with the highest concentration (20 µg ml–1) of the t10, c12 CLA was reduced to 7.9 % (L. lactis CLA) and 19.6 % (E. coli CLA), compared with 95.4 % (control linoleic acid) and 31.7 % (pure t10, c12 CLA). In conclusion, this is believed to represent the first report in which recombinant strains are capable of producing CLA with an anti-proliferative potential.

Abbreviations: CLA, conjugated linoleic acid; c9, t11 CLA, cis-9, trans-11 CLA; t10, c12 CLA, trans-10, cis-12 conjugated linoleic acid; PAI, P. acnes isomerase






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.